Geron Corp reports results for the quarter ended in September 30 - Earnings Summary

Geron

07/11/2024 20:46

* Geron Corp  GERN.OQ  reported a quarterly adjusted loss
of 4
cents​​ per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported EPS
of -8 cents.  The mean expectation of ten analysts for the
quarter was for a loss of 8 cents per share. Wall Street
expected results to range from -10 cents to -8 cents per share.
    * Revenue rose 17,138.4% to $28.27 million from a year ago;
analysts expected $19.01 million. 
    * Geron Corp's reported EPS for the quarter was a loss of 4
cents​.
    * The company reported a quarterly loss of $26.45 million.
    * Geron Corp shares had fallen by 5.9% this quarter and
gained 102.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 6.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Geron Corp is
7.50 
This summary was machine generated from LSEG data November 7 at
08:46 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.08          -0.04          Beat
 Jun. 30 2024      -0.10          -0.10          Met
 Mar. 31 2024      -0.10          -0.09          Beat
 Dec. 31 2023      -0.10          -0.09          Beat